The global cell lysis market is anticipated to grow at a considerable CAGR of 8.6% during the forecast period. The key factors that are contributing to the market growth are the growing number of strategies adopted by key players operating in the market. The companies are adopting mergers, acquisitions, collaboration, and new technology-based product development among others. For instance,
• in May 2022, Tethis S.p.A has launched See.d which is the first universal blood sample preparatory for liquid biopsy analysis this new solution is completely automated and standardized the preparation of a blood sample. In this new solution, all the sample preparation steps are fully automated from the separation of plasma from the cellular fraction, red blood cells lysis to plasma recovery in tubes.
• In November 2021, One BioMed has launched the Xceler8 Platform, which yields the extraction and purification of nucleic acids from biological samples. This new platform is powered by OneTouch Instrument and its touch screen tablet, which automate all nucleic acid extraction steps, including cell lysis, capture, washing, and elution all in less than 30 minutes.
• In May 2020, Aalto Bio Reagents Ltd. has launched its first RNA lysis buffer reagent that supports all the pre-treatment of COVID-19 samples prior to testing. This new RNA Lysis buffer was developed to expand on its testing capabilities and also due to the unavailability of similar reagents.
Browse the full report description of “Cell Lysis Market Size, Share & Trends Analysis Report by Product Type (Instruments, and Reagents & Consumables), by Cell Type (Mammalian Cells, Microbial Cells, and Plant Cells), by Application (Protein Isolation, Downstream Processing, Cell Organelle Isolation, and Nucleic Acid Isolation) and by End-User (Hospital & Diagnostic Labs, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies), Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/cell-lysis-market
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product Type
o By Cell Type
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Claremont BioSolutions, LLC., F. Hoffmann-La Roche, Miltenyi Biotec GmbH, Promega Corp., Qiagen NV, Thermo Fisher Scientific, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Cell Lysis Market Report Segment
By Product Type
By Cell Type
By Application
By End-User
Global Cell Lysis Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cell-lysis-market